Canada Weight Loss Diet Market Size & Outlook, 2026-2034
Canada Weight Loss Diet Market Insights
- As per Deep Market Insights insights, the Canada Weight Loss Diet Market stood at USD 23.57 Billion in 2025 and is anticipated to grow to USD 46.4 Billion by 2034.
- The Canada market is expected to advance at a CAGR of 7.91% from 2026 through 2034.
- In 2025, Meal Replacement Plans accounted for the highest share of the By Product Type market size.
- During the forecast period, Intermittent Fasting Plans is set to register the highest growth, making it the most lucrative By Product Type segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Canada contributed 8.42% to the global Weight Loss Diet Market size in 2025.
- By 2034, United States is forecasted to remain the largest global market for Weight Loss Diet Market.
- In North America, United States is projected to capture the leading share of market size by 2034.
- Among North America markets, Canada is expected to post the fastest growth, reaching USD 46.76 Billion by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 23.57 Billion |
| Market Size In 2034 | USD 46.4 Billion |
| Largest segment | Meal Replacement Plans |
| Units | Revenue in USD Billion |
| CAGR | 7.91% (2026-2034) |
| Segmnetation Covered | |
| By Product Type |
|
| By End-Use |
|
| By Distribution Channel |
|
| By Price Range |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Canada Weight Loss Diet Market By Product Type 2026-2034 (USD Billion)
| By Product Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meal Replacement Plans | XX.x | XX.x | XX.x | 10.61 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Keto Diet Programs | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Intermittent Fasting Plans | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Canada Weight Loss Diet Market By End-Use 2026-2034 (USD Billion)
| By End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adults | XX.x | XX.x | XX.x | 11.6 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fitness Users | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Clinical Weight Management | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Canada Weight Loss Diet Market By Distribution Channel 2026-2034 (USD Billion)
| By Distribution Channel | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Online Platforms | XX.x | XX.x | XX.x | 10.69 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nutrition Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Health Stores | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Canada Weight Loss Diet Market By Price Range 2026-2034 (USD Billion)
| By Price Range | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Economy | XX.x | XX.x | XX.x | 11.12 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Mid-Range | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Premium Clinical | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.